2.07
price down icon1.90%   -0.04
after-market Dopo l'orario di chiusura: 2.10 0.03 +1.45%
loading

In 8 Bio Inc Azioni (INAB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
2.73%
0.107
0.11 0.064 0.023 0.06
Operating Expenses
8.11%
5.201
5.66 6.224 7.109 8.689
Benefits Costs and Expenses
8.11%
5.201
5.66 11.78 7.109 8.689
Costs And Expenses
8.11%
5.201
5.66 6.224 7.109 8.689
Operating Income/Loss
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Income/Loss From Continuing Operations Before Tax
8.22%
-5.094
-5.55 -11.71 -7.086 -8.629
Income/Loss From Continuing Operations After Tax
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Net Income/Loss
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
95.07%
4.1192
83.48 7.8564 47.32 45.13
Diluted Average Shares
95.07%
4.1192
83.48 7.8564 47.32 45.13
Basic Earnings Per Share
1,671%
-1.24
-0.07 -0.04 -0.15 -0.19
Diluted Earnings Per Share
1,671%
-1.24
-0.07 -0.04 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):